Loading...
Loading...
Analysts at Jefferies initiated coverage on
Bellicum Pharmaceuticals, Inc. BLCM with a Buy rating.
The target price for Bellicum Pharmaceuticals is set to $35.
Bellicum Pharmaceuticals' shares jumped 10.86% to close at $31.75 on Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
